APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

15 hedge funds and large institutions have $487K invested in Aptose Biosciences, Inc. in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-7
Holders Change %
-31.82%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
8
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BL
1
Bleichroeder LP
New York
$382K
2
Citadel Advisors
2
Citadel Advisors
Florida
$38K
3
Northwestern Mutual Wealth Management
3
Northwestern Mutual Wealth Management
Wisconsin
$6.49K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$4K
5
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
$319

Top Sellers

1
DS
1
DRW Securities
Illinois
$0
2
SPC
2
Sigma Planning Corp
Michigan
$54.8K
3
UBS Group
3
UBS Group
Switzerland
$0
4
HF
4
HRT Financial
New York
$0
5
AC
5
Annandale Capital
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PCWA
26
Pacific Capital Wealth Advisors
California
– -$1 – –
SPIA
27
Steward Partners Investment Advisory
New York
– -$1 – –
1
2